Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study

doi:10.4239/wjd.v13.i7.543

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3592)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

221

WORD

HTML

1774

Figures (1-4)

406

Tables (1-2)

313

Sum=2764

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

272

Download

556

Sum=828

Jul 15, 2022 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Jul 15, 2022; 13(7): 543-552
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.543

Full Size Figure Download Figure

Figure 1 Flowchart of the study cohort. FMN: Fructosamine; COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.

Citation: Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552
URL: https://www.wjgnet.com/1948-9358/full/v13/i7/543.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i7.543